Delivery Order SPE2DB25D3003-SPE2DB25FPWYW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Miebo 100% eye drop solution in 3ml units. This competitively awarded, non-set-aside contract carries a ceiling value of $7,183.12 and is structured as a firm fixed price delivery order with an ultimate completion date of August 20, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,897.98 for Miebo 100% eye drop (3mL) under a firm fixed price contract. The award was made on September 5, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside delivery order represents a competitive award to the pharmaceutical distributor for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $5,957.57 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Miebo 100% eye drop solution in 3ml quantities, with a contract ceiling value of $7,177.75. This is a firm fixed-price delivery order with an ultimate completion date of August 21, 2025, and no set-aside designation was applied. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major...
- The Defense Logistics Agency awarded a $3,471.72 delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drop solution (3 mL) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price contract represents a non-set-aside competitive award executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Miebo 100% eye drop medication in 3 mL units. This competitively awarded, non-set-aside contract carries a ceiling value of $2,325.38 with a firm fixed price structure and an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The order represents...
- The Defense Logistics Agency awarded a $5,322.00 delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drop (3ml) on September 3, 2025, with completion by September 4, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Miebo 100% eye drops in a 3 milliliter unit, with a ceiling value of $14,043.34 and an ultimate completion date of September 11, 2025. The contract was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,490.73 to AmerisourceBergen Drug Corp on September 4, 2025, for MIEBO 100% eye drop solution in 3ml quantities. The contract is a firm fixed price delivery order with performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 5, 2025. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a $9,567.86 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Miebo 100% eye drop medication in 3 milliliter units. This is a firm fixed price contract with no set-aside designation, reflecting open competition based on AmerisourceBergen's demonstrated capability to meet federal procurement requirements. The contract is set for ultimate completion on September 11, 2025, and will be performed at AmerisourceBergen's...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPWYWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Miebo 100% eye drop solution in 3ml quantities. The contract carries a ceiling value of $23,965.92 and represents a firm fixed-price delivery order with an ultimate completion date of August 15, 2025. This award is a non-set-aside contract, meaning it was competitively awarded and available to all eligible vendors. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement extending through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare systems globally. AmerisourceBergen's portfolio of federal awards demonstrates significant capability in meeting Defense Department medical procurement requirements across multiple therapeutic domains, positioning the company as a critical supplier within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.0k | 8/14/25 |